GDC-0449

vismodegib · Genentech

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for GDC-0449, covering 2014-04-02 to 2021-01-11. Get the full timeline:

Most recent: Clinical Trial Update: To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS) [Phase 2]